Theresa Annette Laguna, MD, MSc

Theresa Annette Laguna, MD, MSc

Pulmonary

On staff since February 2023

Children's Title: Division Chief, Pulmonary and Sleep Medicine

Academic Title: Professor, Department of Pediatrics, University of Washington School of Medicine

Research Center: Center for Respiratory Biology and Therapeutics

"I believe that “if you see it, you can be it.” As a Latinx woman and member of the LGBTQIA+ community in a leadership role in academic medicine, I have an opportunity to mentor and sponsor those coming after me. I strive to bring my authentic self to work every day and use my voice and leadership platforms to advance diversity, equity and inclusion initiatives for patients, trainees and colleagues."

  • Biography

    Dr. Laguna received her undergraduate degree in Molecular and Cellular Biology from the University of New Mexico and her M.D. from the University of California, San Francisco. She completed her Pediatric Residency and Chief Residency at the University of Washington and Seattle Children’s Hospital. She completed her Pediatric Pulmonology Fellowship training and obtained a master’s degree in Clinical Science at the University of Colorado. Upon completion of her training, Dr. Laguna was recruited to the University of Minnesota where she was the Co-Director of the Cystic Fibrosis (CF) Center and Director of the Pediatric CF Program. She then moved to Chicago to be the Division Chief of Pulmonary and Sleep Medicine at Ann & Robert H. Lurie Children’s Hospital and Northwestern University School of Medicine where she also served as the CF Center Director and Director of the Primary Ciliary Dyskinesia (PCD) Center of Excellence. Dr. Laguna was then recruited back to become the new Division Chief of Pulmonary and Sleep Medicine at Seattle Children’s Hospital. Dr. Laguna has built her research career in early lung disease in cystic fibrosis (CF). Her NIH R01 and Cystic Fibrosis Foundation (CFF) grant-funded work focuses on early infections in the CF airway and the role of anaerobic communities in the development of lung disease. She is a national mentor for the CFF and serves on NIH and CFF grant review study sections. She has been recognized for her teaching efforts as an Outstanding Faculty Educator by pediatric residents five times. She is active in diversity, equity and inclusion (DEI) initiatives locally, regionally, and nationally. Dr. Laguna has been active in many professional societies including the American Thoracic Society where she has served as Co-Chair of the DEI Advisory Group, Chair of the Program Committee and will be the incoming Chair of the Pediatrics Assembly.

  • Patient Testimonials

    • Mackenzie Everett, WA 04.01.24

      Dr. Laguna has been the biggest advocate for my son. She listened to me and my concerns and took me seriously. She then advocated for him to get the care he needed by other specialties in a timely manner. I would recommend Dr. Laguna to anyone!

    • Theresa Seattle 01.08.24

      In 2023 my 7 year old son was admitted to the ICU after a soccer game due to his Asthma. During our stay at Children's, we were under the care of Dr. Laguna. She was extremely helpful and took very good care of my son. She also made an effort to teach other providers around her about my sons situation and it was very admirable to see her go above and beyond for my kid. We are so grateful she was able to provide such good care to us. Thanks to her and her team at Children's, my son is healthy and playing soccer once again!

    Recommend Theresa Annette Laguna, MD, MSc

  • Awards and Honors

    Award Name Award Description Awarded By Award Date
    Outstanding Inpatient Faculty Teaching Award Northwestern University, Feinberg School of Medicine, Department of Pediatrics, Pediatric Residency Program 2021 - 2022
    Inducted member of FAME (Feinberg Academy of Medical Educators) FAME recognizes outstanding educators at the Feinberg School of Medicine Northwestern University, Feinberg School of Medicine 2020 - 2023
    Faculty Excellence in Education Award, Faculty Professionalism Award Northwestern University, Feinberg School of Medicine, Department of Pediatrics, Pediatric Residency Program 2019 - 2020
    Outstanding Faculty Educator Award University of Minnesota School of Medicine, Department of Pediatrics, Pediatric Residency Program 2016 - 2017
    Outstanding Faculty Educator Award University of Minnesota School of Medicine, Department of Pediatrics, Pediatric Residency Program 2011 - 2012
    Outstanding Faculty Educator Award University of Minnesota School of Medicine, Department of Pediatrics, Pediatric Residency Program 2009 - 2010

  • Publications

    Other Publications

    • McGarry ME, Gibb ER, Laguna TA, O'Sullivan BP, Sawicki GS, Zobell JT
      How many billions is enough? Prioritizing profits over patients with cystic fibrosis.
      36722731 Pediatric pulmonology, 2023 Feb 1
    • McGarry ME, Gibb ER, Laguna TA, O'Sullivan BP, Sawicki GS, Zobell JT
      How many billions is enough? Prioritizing profits over patients with cystic fibrosis.
      36722731 Pediatric pulmonology, 2023 Feb 1
    • Foster CC, Kwon S, Shah AV, Hodgson CA, Hird-McCorry LP, Janus A, Jedraszko AM, Swanson P, Davis MM, Goodman DM, Laguna TA
      At-home end-tidal carbon dioxide measurement in children with invasive home mechanical ventilation.
      35959530 Pediatric pulmonology, 2022 Nov. : 57(11)2735-2744 PMCID:PMC9588689
    • Foster CC, Kwon S, Shah AV, Hodgson CA, Hird-McCorry LP, Janus A, Jedraszko AM, Swanson P, Davis MM, Goodman DM, Laguna TA
      At-home end-tidal carbon dioxide measurement in children with invasive home mechanical ventilation.
      35959530 Pediatric pulmonology, 2022 Nov. : 57(11)2735-2744 PMCID:PMC9588689
    • Shah A, Laguna TA
      Primary Ciliary Dyskinesia: A Rare and Often Underdiagnosed Disease.
      35156887 Pediatric annals, 2022 Feb. : 51(2)e82-e85
    • Shah A, Laguna TA
      Primary Ciliary Dyskinesia: A Rare and Often Underdiagnosed Disease.
      35156887 Pediatric annals, 2022 Feb. : 51(2)e82-e85
    • O'Connor JB, Mottlowitz M, Kruk ME, Mickelson A, Wagner BD, Harris JK, Wendt CH, Laguna TA
      Network Analysis to Identify Multi-Omic Correlations in the Lower Airways of Children With Cystic Fibrosis.
      35360097 Frontiers in cellular and infection microbiology, 2022 : 12805170 PMCID:PMC8960254
    • O'Connor JB, Mottlowitz M, Kruk ME, Mickelson A, Wagner BD, Harris JK, Wendt CH, Laguna TA
      Network Analysis to Identify Multi-Omic Correlations in the Lower Airways of Children With Cystic Fibrosis.
      35360097 Frontiers in cellular and infection microbiology, 2022 : 12805170 PMCID:PMC8960254
    • Khanal S, Webster M, Niu N, Zielonka J, Nunez M, Chupp G, Slade MD, Cohn L, Sauler M, Gomez JL, Tarran R, Sharma L, Dela Cruz CS, Egan M, Laguna T, Britto CJ
      SPLUNC1: a novel marker of cystic fibrosis exacerbations.
      33958427 The European respiratory journal, 2021 Nov. : 58(5) PMCID:PMC8571118
    • Pittman JE, Khan U, Laguna TA, Heltshe S, Goss CH, Sanders DB
      Rates of adverse and serious adverse events in children with cystic fibrosis.
      33745860 Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2021 Nov. : 20(6)972-977 PMCID:PMC8448791
    • Khanal S, Webster M, Niu N, Zielonka J, Nunez M, Chupp G, Slade MD, Cohn L, Sauler M, Gomez JL, Tarran R, Sharma L, Dela Cruz CS, Egan M, Laguna T, Britto CJ
      SPLUNC1: a novel marker of cystic fibrosis exacerbations.
      33958427 The European respiratory journal, 2021 Nov. : 58(5) PMCID:PMC8571118
    • Pittman JE, Khan U, Laguna TA, Heltshe S, Goss CH, Sanders DB
      Rates of adverse and serious adverse events in children with cystic fibrosis.
      33745860 Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2021 Nov. : 20(6)972-977 PMCID:PMC8448791
    • Palla J, Laguna TA
      Management of chronic pulmonary disease in the time of coronavirus disease 2019.
      33938475 Current opinion in pediatrics, 2021 Jun 1 : 33(3)294-301 PMCID:PMC8097727
    • Palla J, Laguna TA
      Management of chronic pulmonary disease in the time of coronavirus disease 2019.
      33938475 Current opinion in pediatrics, 2021 Jun 1 : 33(3)294-301 PMCID:PMC8097727
    • Williams WA 2nd, Jain M, Laguna TA, McColley SA
      Preferences for disclosing adverse childhood experiences for children and adults with cystic fibrosis.
      33369260 Pediatric pulmonology, 2021 May : 56(5)921-927
    • Williams WA 2nd, Jain M, Laguna TA, McColley SA
      Preferences for disclosing adverse childhood experiences for children and adults with cystic fibrosis.
      33369260 Pediatric pulmonology, 2021 May : 56(5)921-927
    • Ing A, Wlodaver A, Kirschmann D, Toledo E, McCabe C, Kadri S, McIntyre MK, Salazar J, Firestein K, Charrow J, Sanders V, Laguna T, Yap KL
      Transcript analysis for variant classification resolution in a child with primary ciliary dyskinesia.
      33608380 Cold Spring Harbor molecular case studies, 2021 Feb. : 7(1) PMCID:PMC7903884
    • Ing A, Wlodaver A, Kirschmann D, Toledo E, McCabe C, Kadri S, McIntyre MK, Salazar J, Firestein K, Charrow J, Sanders V, Laguna T, Yap KL
      Transcript analysis for variant classification resolution in a child with primary ciliary dyskinesia.
      33608380 Cold Spring Harbor molecular case studies, 2021 Feb. : 7(1) PMCID:PMC7903884
    • O'Connor JB, Mottlowitz MM, Wagner BD, Boyne KL, Stevens MJ, Robertson CE, Harris JK, Laguna TA
      Divergence of bacterial communities in the lower airways of CF patients in early childhood.
      34613995 PloS one, 2021 : 16(10)e0257838 PMCID:PMC8494354
    • O'Connor JB, Mottlowitz MM, Wagner BD, Boyne KL, Stevens MJ, Robertson CE, Harris JK, Laguna TA
      Divergence of bacterial communities in the lower airways of CF patients in early childhood.
      34613995 PloS one, 2021 : 16(10)e0257838 PMCID:PMC8494354
    • Gaston B, Laguna TA, Noah TL, Hagood J, Voynow J, Ferkol T, Hershenson M, Boyne K, Delecaris A, Ross K, Gozal D, Celedón JC, Abman SH, Moore P, Davis S, Cornfield DN, Murphy T
      A proposal for the addressing the needs of the pediatric pulmonary work force.
      32531116 Pediatric pulmonology, 2020 Aug. : 55(8)1859-1867 PMCID:PMC7433343
    • Gaston B, Laguna TA, Noah TL, Hagood J, Voynow J, Ferkol T, Hershenson M, Boyne K, Delecaris A, Ross K, Gozal D, Celedón JC, Abman SH, Moore P, Davis S, Cornfield DN, Murphy T
      A proposal for the addressing the needs of the pediatric pulmonary work force.
      32531116 Pediatric pulmonology, 2020 Aug. : 55(8)1859-1867 PMCID:PMC7433343
    • Fox M, Mercier A, Savant A, Laguna TA
      Cystic fibrosis diagnosed by state newborn screening: Or is it?
      32670584 SAGE open medical case reports, 2020 : 82050313X20939421 PMCID:PMC7339076
    • Fox M, Mercier A, Savant A, Laguna TA
      Cystic fibrosis diagnosed by state newborn screening: Or is it?
      32670584 SAGE open medical case reports, 2020 : 82050313X20939421 PMCID:PMC7339076
    • Bisch AL, Wheatley CM, Baker SE, Peitzman ER, Van Iterson EH, Laguna TA, Morgan WJ, Snyder EM
      Cystic Fibrosis Transmembrane Conductance Regulator Genotype, Not Circulating Catecholamines, Influences Cardiovascular Function in Patients with Cystic Fibrosis.
      30956528 Clinical medicine insights. Circulatory, respiratory and pulmonary medicine, 2019 : 131179548419835788 PMCID:PMC6442074
    • Bisch AL, Wheatley CM, Baker SE, Peitzman ER, Van Iterson EH, Laguna TA, Morgan WJ, Snyder EM
      Cystic Fibrosis Transmembrane Conductance Regulator Genotype, Not Circulating Catecholamines, Influences Cardiovascular Function in Patients with Cystic Fibrosis.
      30956528 Clinical medicine insights. Circulatory, respiratory and pulmonary medicine, 2019 : 131179548419835788 PMCID:PMC6442074
    • Laguna TA, Williams CB, Nunez MG, Welchlin-Bradford C, Moen CE, Reilly CS, Wendt CH
      Biomarkers of inflammation in infants with cystic fibrosis.
      29310632 Respiratory research, 2018 Jan 8 : 19(1)6 PMCID:PMC5759377
    • Laguna TA, Williams CB, Nunez MG, Welchlin-Bradford C, Moen CE, Reilly CS, Wendt CH
      Biomarkers of inflammation in infants with cystic fibrosis.
      29310632 Respiratory research, 2018 Jan 8 : 19(1)6 PMCID:PMC5759377
    • Schendel A, Mai J, Espinosa R, Tomcyzk CT, Laguna TA
      Unexpected Height Loss in an Adolescent With Cystic Fibrosis.
      29761141 Global pediatric health, 2018 : 52333794X18773662 PMCID:PMC5946352
    • Schendel A, Mai J, Espinosa R, Tomcyzk CT, Laguna TA
      Unexpected Height Loss in an Adolescent With Cystic Fibrosis.
      29761141 Global pediatric health, 2018 : 52333794X18773662 PMCID:PMC5946352
    • Zemanick ET, Wagner BD, Robertson CE, Ahrens RC, Chmiel JF, Clancy JP, Gibson RL, Harris WT, Kurland G, Laguna TA, McColley SA, McCoy K, Retsch-Bogart G, Sobush KT, Zeitlin PL, Stevens MJ, Accurso FJ, Sagel SD, Harris JK
      Airway microbiota across age and disease spectrum in cystic fibrosis.
      29146601 The European respiratory journal, 2017 Nov. : 50(5) PMCID:PMC5935257
    • Zemanick ET, Wagner BD, Robertson CE, Ahrens RC, Chmiel JF, Clancy JP, Gibson RL, Harris WT, Kurland G, Laguna TA, McColley SA, McCoy K, Retsch-Bogart G, Sobush KT, Zeitlin PL, Stevens MJ, Accurso FJ, Sagel SD, Harris JK
      Airway microbiota across age and disease spectrum in cystic fibrosis.
      29146601 The European respiratory journal, 2017 Nov. : 50(5) PMCID:PMC5935257
    • Mikesell CL, Kempainen RR, Laguna TA, Menk JS, Wey AR, Gaillard PR, Regelmann WE
      Objective Measurement of Adherence to Out-Patient Airway Clearance Therapy by High-Frequency Chest Wall Compression in Cystic Fibrosis.
      28424226 Respiratory care, 2017 July : 62(7)920-927 PMCID:PMC6373861
    • Mikesell CL, Kempainen RR, Laguna TA, Menk JS, Wey AR, Gaillard PR, Regelmann WE
      Objective Measurement of Adherence to Out-Patient Airway Clearance Therapy by High-Frequency Chest Wall Compression in Cystic Fibrosis.
      28424226 Respiratory care, 2017 July : 62(7)920-927 PMCID:PMC6373861
    • Wojciechowski AR, Tomczyk CT, Laguna TA
      Abdominal Pain in a 17-Year-Old Girl With Pancreatic Insufficient Cystic Fibrosis.
      26968630 Clinical pediatrics, 2017 Jan. : 56(1)100-103 PMCID:PMC5554093
    • Wojciechowski AR, Tomczyk CT, Laguna TA
      Abdominal Pain in a 17-Year-Old Girl With Pancreatic Insufficient Cystic Fibrosis.
      26968630 Clinical pediatrics, 2017 Jan. : 56(1)100-103 PMCID:PMC5554093
    • Laguna TA, Wagner BD, Williams CB, Stevens MJ, Robertson CE, Welchlin CW, Moen CE, Zemanick ET, Harris JK
      Airway Microbiota in Bronchoalveolar Lavage Fluid from Clinically Well Infants with Cystic Fibrosis.
      27930727 PloS one, 2016 : 11(12)e0167649 PMCID:PMC5145204
    • Laguna TA, Wagner BD, Williams CB, Stevens MJ, Robertson CE, Welchlin CW, Moen CE, Zemanick ET, Harris JK
      Airway Microbiota in Bronchoalveolar Lavage Fluid from Clinically Well Infants with Cystic Fibrosis.
      27930727 PloS one, 2016 : 11(12)e0167649 PMCID:PMC5145204
    • Laguna TA, Reilly CS, Williams CB, Welchlin C, Wendt CH
      Metabolomics analysis identifies novel plasma biomarkers of cystic fibrosis pulmonary exacerbation.
      26115542 Pediatric pulmonology, 2015 Sept. : 50(9)869-77 PMCID:PMC5553866
    • Zemanick ET, Laguna TA
      Editorial Commentary: Pseudomonas aeruginosa Eradication: How Do We Measure Success?
      25972023 Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015 Sep 1 : 61(5)716-8 PMCID:PMC4530724
    • Zemanick ET, Laguna TA
      Editorial Commentary: Pseudomonas aeruginosa Eradication: How Do We Measure Success?
      25972023 Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015 Sep 1 : 61(5)716-8 PMCID:PMC4530724
    • Laguna TA, Reilly CS, Williams CB, Welchlin C, Wendt CH
      Metabolomics analysis identifies novel plasma biomarkers of cystic fibrosis pulmonary exacerbation.
      26115542 Pediatric pulmonology, 2015 Sept. : 50(9)869-77 PMCID:PMC5553866
    • Laguna TA, Williams CB, Brandy KR, Welchlin-Bradford C, Moen CE, Reilly CS, Wendt CH
      Sputum club cell protein concentration is associated with pulmonary exacerbation in cystic fibrosis.
      25456770 Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2015 May : 14(3)334-40 PMCID:PMC4408227
    • Laguna TA, Williams CB, Brandy KR, Welchlin-Bradford C, Moen CE, Reilly CS, Wendt CH
      Sputum club cell protein concentration is associated with pulmonary exacerbation in cystic fibrosis.
      25456770 Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2015 May : 14(3)334-40 PMCID:PMC4408227
    • Taylor MK, McCauley LA, Alexander CK, Laguna TA
      Fifteen-year-old girl with severe obstructive lung disease, pansinusitis, and failure to thrive.
      24817075 Clinical pediatrics, 2014 Sept. : 53(10)1016-8
    • Taylor MK, McCauley LA, Alexander CK, Laguna TA
      Fifteen-year-old girl with severe obstructive lung disease, pansinusitis, and failure to thrive.
      24817075 Clinical pediatrics, 2014 Sept. : 53(10)1016-8
    • McCauley LA, Thomas W, Laguna TA, Regelmann WE, Moran A, Polgreen LE
      Vitamin D deficiency is associated with pulmonary exacerbations in children with cystic fibrosis.
      24083951 Annals of the American Thoracic Society, 2014 Feb. : 11(2)198-204 PMCID:PMC3972970
    • McCauley LA, Thomas W, Laguna TA, Regelmann WE, Moran A, Polgreen LE
      Vitamin D deficiency is associated with pulmonary exacerbations in children with cystic fibrosis.
      24083951 Annals of the American Thoracic Society, 2014 Feb. : 11(2)198-204 PMCID:PMC3972970
    • Paulson NB, Gilbertsen AJ, Dalluge JJ, Welchlin CW, Hughes J, Han W, Blackwell TS, Laguna TA, Williams BJ
      The arginine decarboxylase pathways of host and pathogen interact to impact inflammatory pathways in the lung.
      25350753 PloS one, 2014 : 9(10)e111441 PMCID:PMC4211729
    • Paulson NB, Gilbertsen AJ, Dalluge JJ, Welchlin CW, Hughes J, Han W, Blackwell TS, Laguna TA, Williams BJ
      The arginine decarboxylase pathways of host and pathogen interact to impact inflammatory pathways in the lung.
      25350753 PloS one, 2014 : 9(10)e111441 PMCID:PMC4211729
    • Bellin MD, Laguna T, Leschyshyn J, Regelmann W, Dunitz J, Billings J, Moran A
      Insulin secretion improves in cystic fibrosis following ivacaftor correction of CFTR: a small pilot study.
      23952705 Pediatric diabetes, 2013 Sept. : 14(6)417-21 PMCID:PMC3804832
    • Bellin MD, Laguna T, Leschyshyn J, Regelmann W, Dunitz J, Billings J, Moran A
      Insulin secretion improves in cystic fibrosis following ivacaftor correction of CFTR: a small pilot study.
      23952705 Pediatric diabetes, 2013 Sept. : 14(6)417-21 PMCID:PMC3804832
    • Moore BM, Laguna TA, Liu M, McNamara JJ
      Increased adherence to CFF practice guidelines for pulmonary medications correlates with improved FEV1.
      22997186 Pediatric pulmonology, 2013 Aug. : 48(8)747-53 PMCID:PMC3856882
    • Moore BM, Laguna TA, Liu M, McNamara JJ
      Increased adherence to CFF practice guidelines for pulmonary medications correlates with improved FEV1.
      22997186 Pediatric pulmonology, 2013 Aug. : 48(8)747-53 PMCID:PMC3856882
    • Zemanick ET, Harris JK, Wagner BD, Robertson CE, Sagel SD, Stevens MJ, Accurso FJ, Laguna TA
      Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations.
      23646159 PloS one, 2013 : 8(4)e62917 PMCID:PMC3639911
    • Zemanick ET, Harris JK, Wagner BD, Robertson CE, Sagel SD, Stevens MJ, Accurso FJ, Laguna TA
      Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations.
      23646159 PloS one, 2013 : 8(4)e62917 PMCID:PMC3639911
    • Laguna TA
      To sweat or not to sweat: is that enough to diagnose cystic fibrosis?
      23071183 American journal of respiratory and critical care medicine, 2012 Oct 15 : 186(8)700-1
    • Laguna TA
      To sweat or not to sweat: is that enough to diagnose cystic fibrosis?
      23071183 American journal of respiratory and critical care medicine, 2012 Oct 15 : 186(8)700-1
    • Laguna TA, Wagner BD, Starcher B, Luckey Tarro HK, Mann SA, Sagel SD, Accurso FJ
      Urinary desmosine: a biomarker of structural lung injury during CF pulmonary exacerbation.
      22431382 Pediatric pulmonology, 2012 Sept. : 47(9)856-63 PMCID:PMC3856884
    • Laguna TA, Wagner BD, Starcher B, Luckey Tarro HK, Mann SA, Sagel SD, Accurso FJ
      Urinary desmosine: a biomarker of structural lung injury during CF pulmonary exacerbation.
      22431382 Pediatric pulmonology, 2012 Sept. : 47(9)856-63 PMCID:PMC3856884
    • Laguna TA, Lin N, Wang Q, Holme B, McNamara J, Regelmann WE
      Comparison of quantitative sweat chloride methods after positive newborn screen for cystic fibrosis.
      22786625 Pediatric pulmonology, 2012 Aug. : 47(8)736-42 PMCID:PMC3856863
    • Laguna TA, Lin N, Wang Q, Holme B, McNamara J, Regelmann WE
      Comparison of quantitative sweat chloride methods after positive newborn screen for cystic fibrosis.
      22786625 Pediatric pulmonology, 2012 Aug. : 47(8)736-42 PMCID:PMC3856863
    • Moore BM, Blumberg K, Laguna TA, Liu M, Zielinski EE, Kurachek SC
      Incidental sinusitis in a pediatric intensive care unit.
      21283043 Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2012 March : 13(2)e64-8 PMCID:PMC3856864
    • Moore BM, Blumberg K, Laguna TA, Liu M, Zielinski EE, Kurachek SC
      Incidental sinusitis in a pediatric intensive care unit.
      21283043 Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2012 March : 13(2)e64-8 PMCID:PMC3856864
    • Dunn CT, Skrypek MM, Powers AL, Laguna TA
      The need for vigilance: the case of a false-negative newborn screen for cystic fibrosis.
      21727111 Pediatrics, 2011 Aug. : 128(2)e446-9 PMCID:PMC8202520
    • Dunn CT, Skrypek MM, Powers AL, Laguna TA
      The need for vigilance: the case of a false-negative newborn screen for cystic fibrosis.
      21727111 Pediatrics, 2011 Aug. : 128(2)e446-9 PMCID:PMC8202520
    • Frohnert BI, Ode KL, Moran A, Nathan BM, Laguna T, Holme B, Thomas W
      Impaired fasting glucose in cystic fibrosis.
      21115768 Diabetes care, 2010 Dec. : 33(12)2660-4 PMCID:PMC2992208
    • Frohnert BI, Ode KL, Moran A, Nathan BM, Laguna T, Holme B, Thomas W
      Impaired fasting glucose in cystic fibrosis.
      21115768 Diabetes care, 2010 Dec. : 33(12)2660-4 PMCID:PMC2992208
    • Ode KL, Frohnert B, Laguna T, Phillips J, Holme B, Regelmann W, Thomas W, Moran A
      Oral glucose tolerance testing in children with cystic fibrosis.
      20202149 Pediatric diabetes, 2010 Nov. : 11(7)487-92 PMCID:PMC3856892
    • Ode KL, Frohnert B, Laguna T, Phillips J, Holme B, Regelmann W, Thomas W, Moran A
      Oral glucose tolerance testing in children with cystic fibrosis.
      20202149 Pediatric diabetes, 2010 Nov. : 11(7)487-92 PMCID:PMC3856892
    • Nathan BM, Laguna T, Moran A
      Recent trends in cystic fibrosis-related diabetes.
      20489612 Current opinion in endocrinology, diabetes, and obesity, 2010 Aug. : 17(4)335-41
    • Nathan BM, Laguna T, Moran A
      Recent trends in cystic fibrosis-related diabetes.
      20489612 Current opinion in endocrinology, diabetes, and obesity, 2010 Aug. : 17(4)335-41
    • Moore BM, Rothman SM, Clark HB, Vehe RK, Laguna TA
      Epilepsy: an anticipatory presentation of pediatric Wegener's granulomatosis.
      20682204 Pediatric neurology, 2010 July : 43(1)49-52
    • Moore BM, Rothman SM, Clark HB, Vehe RK, Laguna TA
      Epilepsy: an anticipatory presentation of pediatric Wegener's granulomatosis.
      20682204 Pediatric neurology, 2010 July : 43(1)49-52
    • Wagner BD, Accurso FJ, Laguna TA
      The applicability of urinary creatinine as a method of specimen normalization in the cystic fibrosis population.
      20227353 Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2010 May : 9(3)212-6 PMCID:PMC2883692
    • Wagner BD, Accurso FJ, Laguna TA
      The applicability of urinary creatinine as a method of specimen normalization in the cystic fibrosis population.
      20227353 Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2010 May : 9(3)212-6 PMCID:PMC2883692
    • Laguna TA, Wagner BD, Luckey HK, Mann SA, Sagel SD, Regelmann W, Accurso FJ
      Sputum desmosine during hospital admission for pulmonary exacerbation in cystic fibrosis.
      19567495 Chest, 2009 Dec. : 136(6)1561-1568 PMCID:PMC2789924
    • Laguna TA, Wagner BD, Luckey HK, Mann SA, Sagel SD, Regelmann W, Accurso FJ
      Sputum desmosine during hospital admission for pulmonary exacerbation in cystic fibrosis.
      19567495 Chest, 2009 Dec. : 136(6)1561-1568 PMCID:PMC2789924
    • Laguna TA, Sontag MK, Osberg I, Wagener JS, Accurso FJ, Sokol RJ
      Decreased total serum coenzyme-Q10 concentrations: a longitudinal study in children with cystic fibrosis.
      18534204 The Journal of pediatrics, 2008 Sept. : 153(3)402-7
    • Laguna TA, Sagel SD, Sontag MK, Accurso FJ
      The clinical course of a Mexican female with cystic fibrosis and the novel genotype S531P/S531P.
      18463004 Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2008 Sept. : 7(5)454-6
    • Laguna TA, Sontag MK, Osberg I, Wagener JS, Accurso FJ, Sokol RJ
      Decreased total serum coenzyme-Q10 concentrations: a longitudinal study in children with cystic fibrosis.
      18534204 The Journal of pediatrics, 2008 Sept. : 153(3)402-7
    • Laguna TA, Sagel SD, Sontag MK, Accurso FJ
      The clinical course of a Mexican female with cystic fibrosis and the novel genotype S531P/S531P.
      18463004 Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2008 Sept. : 7(5)454-6
    • Gerszten RE, Accurso F, Bernard GR, Caprioli RM, Klee EW, Klee GG, Kullo I, Laguna TA, Roth FP, Sabatine M, Srinivas P, Wang TJ, Ware LB
      Challenges in translating plasma proteomics from bench to bedside: update from the NHLBI Clinical Proteomics Programs.
      18456800 American journal of physiology. Lung cellular and molecular physiology, 2008 July : 295(1)L16-22 PMCID:PMC2494793
    • Gerszten RE, Accurso F, Bernard GR, Caprioli RM, Klee EW, Klee GG, Kullo I, Laguna TA, Roth FP, Sabatine M, Srinivas P, Wang TJ, Ware LB
      Challenges in translating plasma proteomics from bench to bedside: update from the NHLBI Clinical Proteomics Programs.
      18456800 American journal of physiology. Lung cellular and molecular physiology, 2008 July : 295(1)L16-22 PMCID:PMC2494793

Overview

Board Certification(s)

Pediatric Pulmonology

Medical/Professional School

University of California San Francisco School of Medicine, San Francisco, CA

Residency

Seattle Children's Hospital, Seattle, WA
University of Washington School of Medicine, Seattle, WA

Fellowship

University of Colorado at Denver-GME, Aurora, CO

Clinical Interests

Cystic fibrosis, primary ciliary dyskinesia, pulmonary complications of stem cell transplantation, interstitial lung disease, health disparities

Research Description

The development and progression of lung disease in CF and PCD, health disparities, DEI in the workforce. Dr. Laguna’s current funded research program investigates the impact of bacterial and fungal communities identified by next generation sequencing methods on inflammation and lung disease progression in bronchoalveolar lavage fluid obtained from the pediatric CF airway.